John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


Publication year:
All
1 - 10 out of 30Page size: 10
  1. 2017
  2. Published

    Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency

    Stemmerik, M. G., Madsen, K. L., Laforêt, P., Buch, A. E. & Vissing, John, 12 Dec 2017, In: Neurology. 89, 24, p. 2491-2494 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1  deficiency

    Ben Yaou, R., Hubert, A., Nelson, I., Dahlqvist, J. R., Gaist, D., Streichenberger, N., Beuvin, M., Krahn, M., Petiot, P., Parisot, F., Michel, F., Malfatti, E., Romero, N., Carlier, R. Y., Eymard, B., Labrune, P., Duno, M., Krag, T., Cerino, M., Bartoli, M. & 4 others, Bonne, G., Vissing, John, Laforet, P. & Petit, F. M., Dec 2017, In: Neurology: Genetics. 3, 6, 11 p., e208.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Mitochondrial DNA mutation load in a family with the m.8344A>G point mutation and lipomas: a case study

    Jeppesen, T. D., Al-Hashimi, N., Duno, M., Wibrand, F., Andersen, G. & Vissing, John, Dec 2017, In: Clinical Case Reports. 5, 12, p. 2034-2039 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Howard, J. F., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., Jacob, S., Vissing, John, Burns, T. M., Kissel, J. T., Muppidi, S., Nowak, R. J., O'Brien, F., Wang, J., Mantegazza, R. & REGAIN Study Group, R. S. G., Dec 2017, In: Lancet Neurology. 16, 12, p. 976-986 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Pure exercise intolerance and ophthalmoplegia associated with the m.12,294G > A mutation in the MT-TL2 gene: a case report

    Soldath, P., Madsen, K. L., Buch, A. E., Duno, M., Wibrand, F. & Vissing, John, Oct 2017, In: BMC Musculoskeletal Disorders. 18, 6 p., 419.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    DOK7 congenital myasthenia may be associated with severe mitral valve insufficiency

    Gaist, D., Mogensen, J., Pedersen, E. G., Schrøder, H. D., Vissing, John, Andersen, H. & Hertz, J. M., 15 Aug 2017, In: Journal of the Neurological Sciences. 379, p. 217-218 2 p.

    Research output: Contribution to journal › Comment/debate › Research

  8. Published

    Skeletal muscle metabolism during prolonged exercise in Pompe disease

    Preisler, N., Laforêt, P., Madsen, K. L., Husu, E., Vissing, C. R., Hedermann, G., Galbo, Henrik, Lindberg, C. & Vissing, John, Aug 2017, In: Endocrine Connections. 6, 6, p. 384-394 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

    van der Ploeg, A. T., Kruijshaar, M. E., Toscano, A., Laforêt, P., Angelini, C., Lachmann, R. H., Pascual Pascual, S. I., Roberts, M., Rösler, K., Stulnig, T. M., van Doorn, P. A., Van den Bergh, P. Y. K., Vissing, John, Schoser, B. & European Pompe Consortium, E. P. C., Jun 2017, In: European Journal of Neurology. 24, 6, p. 768-e31

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Apr 2017, In: Neurology: Genetics. 3, 2, 15 p., e140.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy

    Svenstrup, K., Nielsen, T. T., Aidt, F., Rostgaard, N., Duno, M., Wibrand, F., Vinther-Jensen, T., Law, Ian, Vissing, John, Roos, P., Hjermind, L. E. & Nielsen, Jørgen Erik, Feb 2017, In: The Cerebellum. 16, 1, p. 62-67 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 915367